Clinical Trial Results Home

  STEMI: Primary PCI

Primary PCI:

ALKK PTCA in stable survivors of acute MI vs medical therapy

 

BRAVE-2 Benefit of primary PCI among asymptomatic pts presenting late in STEMI

 

CADILLAC Abciximab & Bare Metal Stenting in STEMI

 

CAPTIM Comparison of Angioplasty and Prehospital Thrombolysis in Acute Myocardial Infarction

 

DANAMI II Danish Myocardial Infarction Study

 

MATE  from Peter McCullough, M.D., Medicine vs Angiography in Thrombolytic (Reperfusion) Exclusion Patients

 

PAMI Stent: 6 Month Results

 

PAMI Stent: 1 Year Results

 

PAMI Stent: Mortality among patients with a closed artery on presentation to cath lab

Facilitated PCI:

ADMIRAL Abciximab pre-PCI for STEMI

 

ADVANCE Additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty *Provided by Dr. Valgimigli, University of Ferrara Italy & Erasmus MC, the Netherlands

 

CADILLAC vs ADMIRAL

 

CAPITAL AMI Combined Angioplasty and Pharmacological Intervention Versus Thrombolytics Alone in Acute Myocardial Infarction

 

GRACIA-2 Safety and efficacy of optimal primary PCI vs facilitated PCI with TNK+stenting in patients with ST elevation MI

 

INTAMI Integrilin in Acute Myocardial Infarction

 

PACT Half dose tPA before PCI in STEMI

 

REACT Rescue Angioplasty Versus Conservative Therapy or

Repeat Thrombolysis Trial

 

STRATEGY Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent vs. Abciximab and Bare-Metal Stent in Myocardial Infarction

 

TETAMI Treatment of Enoxaparin and Tirofiban in Acute Myocardial Infarction

 

TIGER PA Aggrastat before primary PCI

Distal Protection:

 

AiMI Thrombectomy With the AngioJet in Acute Myocardial Infarction

 

EMERALD Enhanced Myocardial Efficacy and Removal by Aspiration of Liberated Debris

 

Filterwire FilterWire-Ex as an Adjunct to Primary PCI